WO2025039676 - PAN-KRAS PROTEIN TARGETED DEGRADER COMPOUND AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2025/039676
Publication Date
27.02.2025
International Application No.
PCT/CN2024/097694
International Filing Date
06.06.2024
Title **
[English]
PAN-KRAS PROTEIN TARGETED DEGRADER COMPOUND AND USE THEREOF
[French]
COMPOSÉ DE DÉGRADATION CIBLÉ DE PROTÉINE PAN-KRAS ET SON UTILISATION
[Chinese]
一种靶向泛KRAS蛋白降解剂的化合物及其应用
Applicants **
BETTA PHARMACEUTICALS CO., LTD
Inventors
XU, Renqi
YANG, Xiaofeng
ZHANG, Hongbo
LU, Lu
ZHENG, Hang
WANG, Ze
WANG, Wei
LI, Shusen
HE, Jiangqi
SHI, Zhaotao
WANG, Dong
LIN, Yuanwang
LI, Tengfei
FANG, Longcheng
TAN, Yaoming
XU, Yanjie
XIA, Hongfeng
LU, Yuan
WU, Hao
ZHOU, Quan
LAN, Hong
WANG, Jiabing
DING, Lieming
Priority Data
202311043105.0
18.08.2023
CN
202311266772.5
28.09.2023
CN
202410100382.9
24.01.2024
CN
202410623723.0
17.05.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5731 | |
| EPO | Filing, Examination, Granting | 37876 | |
| Japan | Filing, Examination, Granting | 3165 | |
| South Korea | Filing, Examination, Granting | 4303 | |
| USA | Filing, Examination, Granting | 12840 |
Total:
63,915
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to a pan-KRAS protein targeted modulator compound and the use thereof. Specifically, the present invention relates to a pan-KRAS protein targeted modulator compound as shown in general formula (A), a preparation method therefor, and the pharmaceutical use thereof.[French]
La présente invention concerne un composé modulateur ciblé de protéine pan-KRAS et son utilisation. Plus particulièrement, la présente invention concerne un composé modulateur ciblé de protéine pan-KRAS tel que représenté dans la formule générale (A), son procédé de préparation et son utilisation pharmaceutique.[Chinese]
涉及一种靶向泛KRAS蛋白调节剂的化合物及其应用。具体而言，涉及一种含有通式(A)所示的靶向泛KRAS蛋白调节剂化合物、其制备方法，及其在医药上的应用。